- Home
- RSSS vs VERU Comparison
RSSS vs VERU Comparison
Compare RSSS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- VERU
- Stock Information
- Founded
- RSSS 2006
- VERU 1971
- Country
- RSSS United States
- VERU United States
- Employees
- RSSS N/A
- VERU N/A
- Industry
- RSSS Business Services
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- VERU Health Care
- Exchange
- RSSS Nasdaq
- VERU Nasdaq
- Market Cap
- RSSS 90.6M
- VERU 94.5M
- IPO Year
- RSSS N/A
- VERU 1990
- Fundamental
- Price
- RSSS $2.69
- VERU $0.58
- Analyst Decision
- RSSS
- VERU Strong Buy
- Analyst Count
- RSSS 0
- VERU 2
- Target Price
- RSSS N/A
- VERU $4.00
- AVG Volume (30 Days)
- RSSS 43.1K
- VERU 4.4M
- Earning Date
- RSSS 05-08-2025
- VERU 08-07-2025
- Dividend Yield
- RSSS N/A
- VERU N/A
- EPS Growth
- RSSS N/A
- VERU N/A
- EPS
- RSSS N/A
- VERU N/A
- Revenue
- RSSS $48,753,578.00
- VERU $16,886,419.00
- Revenue This Year
- RSSS $12.42
- VERU N/A
- Revenue Next Year
- RSSS $7.47
- VERU N/A
- P/E Ratio
- RSSS N/A
- VERU N/A
- Revenue Growth
- RSSS 14.85
- VERU 134.43
- 52 Week Low
- RSSS $2.32
- VERU $0.45
- 52 Week High
- RSSS $4.24
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- RSSS 44.29
- VERU 52.23
- Support Level
- RSSS $2.60
- VERU $0.56
- Resistance Level
- RSSS $2.99
- VERU $0.74
- Average True Range (ATR)
- RSSS 0.14
- VERU 0.05
- MACD
- RSSS -0.01
- VERU -0.00
- Stochastic Oscillator
- RSSS 23.08
- VERU 36.26
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.